Register of
Medicinal Products

Product class: Authorized package
Medicinal product class: For human use
Package code: 1165722
Name of medicinal product: ANGELIQ
Active substances:
Drospirenone+Estradiol
Estonian, English, Latin
ATC code: G03FA17
Dosage form: film-coated tablet
Route of administration: oral use
Strengh: 2mg+1mg
Amount in package: 84TK
Legal status for supply*: Subject to medicinal prescription
Class of active substance:  
Additional information:  
Indication: Hormone replacement therapy for oestrogen deficiency symptoms in postmenopausal women more than 1 year post menopause. Prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis. (See also Section 4.4) The experience treating women older than 65 years is limited.
Safety features: Yes
Summary of product characteristics (SPC):  (last updated February 16, 2024)
Package information leaflet (PIL): EST  (last updated February 16, 2024)
Labelling:  (last updated January 9, 2018)
Last imported to Estonia: Never imported to Estonia
Marketing authorization holder: Bayer AG 
Marketing authorization number: 472405 
Marketing authorization issued on: May 12, 2005 
Marketing authorization expires on: Unlimited 
Marketing authorization procedure type: Mutual recognition 
Reference price:   
Under reference price:   
Reference price of daily dose:   
Entry/Changing date: February 16, 2024
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere